To study female urogenital tract mycoplasma infection and drug - resistance evolution.
目的研究女性泌尿生殖道支原体感染及耐药性变迁。
Objective: To find out the status of infection of three pathogens in urogenital tract of female patients.
目的：分析、了解女性泌尿生殖道3种病原微生物感染情况。
Chlamydia and Mycoplasma invasive human urogenital tract, there are 1 to 3 weeks or longer incubation period.
衣原体和支原体侵入人体泌尿生殖道后，都有1 ~3周或更长的潜伏期。
Objective Investigation of non-gonococcal urogenital tract infections in patients with mycoplasma infection and drug resistance status.
目的调查非淋菌性泌尿生殖道感染患者中支原体感染及耐药性状况。
System real time quantitative RT-PCR technology and immunohistochemistry were used to detect the Chlamydia trachomatis urogenital tract, the expression of UU.
结果：①实验组女性泌尿生殖道沙眼衣原体、解脲支原体的表达高于对照组。
CONCLUSION: Azithromycin is an effective agent in the treatment of the acquired lower respiratory tract infection and urogenital tract infection with slight adverse reaction.
结论：阿奇霉素是治疗院外获得性呼吸道与泌尿生殖道感染的有效和安全的药物。
Methods Bacteria, mycoplasma and chlamydia were isolated from the urogenital tract secretion by artifical culture, and their antibiotic susceptibility was detected by disk diffusion.
目的：从泌尿生殖道分泌物中分离培养细菌、支原体及衣原体，了解细菌对多种抗菌药物的敏感情况。
Conclusion: Azithromycin is an effective agent in the treatment of the acquired lower respiratory tract infection, urogenital and urogenital tract infection with slight adverse reaction.
结论：阿奇霉素是治疗院外获得性呼吸道与泌尿生殖道感染的有效和安全的药物。
Conclusion: Azithromycin is an effective agent in the treatment of the acquired lower respiratory tract infection, urogenital and urogenital tract infection with slight adverse reaction.
结论：阿奇霉素是治疗院外获得性呼吸道与泌尿生殖道感染的有效和安全的药物。
应用推荐